{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:08:05Z","timestamp":1758672485412,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,22]]},"DOI":"10.7759\/cureus.92985","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:39:11Z","timestamp":1758609551000},"source":"Crossref","is-referenced-by-count":0,"title":["Neonatal Outcome After Expectant Management of Preterm Premature Rupture of Membranes (PPROM) Between 34+0 and 36+6 Weeks of Gestation: A Single-Center Cohort Study"],"prefix":"10.7759","author":[{"given":"Amrei","family":"Welp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Christesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann Lennard","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Dracopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perke","family":"Pricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Rody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Weichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gembicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12329","article-title":"Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37\u00a0weeks (PPROMEXIL trial)","volume":"93","author":"Vijgen SM","year":"2014","unstructured":"Vijgen SM, van der Ham DP, Bijlenga D, et al.. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37\u00a0weeks (PPROMEXIL trial). Acta Obstet Gynecol Scand. 2014, 93:374-81. 10.1111\/aogs.12329","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2016.05.011","article-title":"We should proceed with caution when it comes to antenatal corticosteroids after 34 weeks","volume":"39","author":"Nowik CM","year":"2017","unstructured":"Nowik CM, Davies GA, Smith GN. We should proceed with caution when it comes to antenatal corticosteroids after 34 weeks. J Obstet Gynaecol Can. 2017, 39:49-51. 10.1016\/j.jogc.2016.05.011","journal-title":"J Obstet Gynaecol Can"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2019.03.001","article-title":"Antenatal corticosteroids after 34\u202fweeks' gestation: do we have the evidence?","volume":"24","author":"Groom KM","year":"2019","unstructured":"Groom KM. Antenatal corticosteroids after 34\u202fweeks' gestation: do we have the evidence?. Semin Fetal Neonatal Med. 2019, 24:189-96. 10.1016\/j.siny.2019.03.001","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001712","article-title":"Practice bulletin no. 172: premature rupture of membranes","volume":"128","year":"2016","unstructured":"Practice bulletin no. 172. premature rupture of membranes. Obstet Gynecol. 2016, 128:e165-77. 10.1097\/AOG.0000000000001712","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003700","article-title":"Prelabor rupture of membranes: ACOG practice bulletin, number 217","volume":"135","year":"2020","unstructured":"Prelabor rupture of membranes. ACOG practice bulletin, number 217. Obstet Gynecol. 2020, 135:e80-97. 10.1097\/AOG.0000000000003700","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005302.pub3","article-title":"Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)","volume":"1","author":"Middleton P","year":"2017","unstructured":"Middleton P, Shepherd E, Flenady V, McBain RD, Crowther CA. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst Rev. 2017, 1:CD005302. 10.1002\/14651858.CD005302.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). (2020). https.\/\/register.awmf.org\/de\/leitlinien\/detail\/015-025."},{"key":"ref8","unstructured":"Intrapartum care. evidence reviews for initial assessment of women reporting prelabour rupture of membranes. (2021). https:\/\/www.nice.org.uk\/guidance\/ng201\/evidence."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.02.021","article-title":"Preterm premature rupture of the membranes: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF)","volume":"236","author":"Schmitz T","year":"2019","unstructured":"Schmitz T, Sentilhes L, Lorthe E, et al.. Preterm premature rupture of the membranes: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2019, 236:1-6. 10.1016\/j.ejogrb.2019.02.021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.07.024","article-title":"Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial","volume":"207","author":"van der Ham DP","year":"2012","unstructured":"van der Ham DP, van der Heyden JL, Opmeer BC, et al.. Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol. 2012, 207:276.e1-10. 10.1016\/j.ajog.2012.07.024","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00724-2","article-title":"Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial","volume":"387","author":"Morris JM","year":"2016","unstructured":"Morris JM, Roberts CL, Bowen JR, et al.. Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet. 2016, 387:444-52. 10.1016\/S0140-6736(15)00724-2","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101563","article-title":"PPROM in the late preterm period: an argument for expectant management","volume":"7","author":"Lee D","year":"2025","unstructured":"Lee D, Lynch TA. PPROM in the late preterm period: an argument for expectant management. Am J Obstet Gynecol MFM. 2025, 7:101563. 10.1016\/j.ajogmf.2024.101563","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2020-0297","article-title":"Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes","volume":"49","author":"Romero R","year":"2021","unstructured":"Romero R, Pacora P, Kusanovic JP, et al.. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Journal of Perinatal Medicine. 2021, 49:275-298. 10.1515\/jpm-2020-0297","journal-title":"Journal of Perinatal Medicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2015.07.015","article-title":"Labor induction in the patient with preterm premature rupture of membranes","volume":"39","author":"Packard RE","year":"2015","unstructured":"Packard RE, Mackeen AD. Labor induction in the patient with preterm premature rupture of membranes. Semin Perinatol. 2015, 39:495-500. 10.1053\/j.semperi.2015.07.015","journal-title":"Semin Perinatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001246","article-title":"Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop","volume":"127","author":"Higgins RD","year":"2016","unstructured":"Higgins RD, Saade G, Polin RA, et al.. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016, 127:426-36. 10.1097\/AOG.0000000000001246","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31829bdc5c","article-title":"A proposal for a new method of evaluation of the newborn infant","volume":"120","author":"Apgar V","year":"2015","unstructured":"Apgar V. A proposal for a new method of evaluation of the newborn infant. Anesth Analg. 2015, 120:1056-9. 10.1213\/ANE.0b013e31829bdc5c","journal-title":"Anesth Analg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20242473","article-title":"Expectant management versus termination of pregnancy in preterm premature rupture of membranes at 34 to 36+6 weeks gestation: a randomised control trial","volume":"13","author":"Kaur A","year":"2024","unstructured":"Kaur A, Jain V, Bagga R, Radhika S, Venkataseshan S. Expectant management versus termination of pregnancy in preterm premature rupture of membranes at 34 to 36+6 weeks gestation: a randomised control trial. Int J Reprod Contracept Obstet Gynecol. 2024, 13:2308-15. 10.18203\/2320-1770.ijrcog20242473","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004735.pub4","article-title":"Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome","volume":"3","author":"Bond DM","year":"2017","unstructured":"Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017, 3:CD004735. 10.1002\/14651858.CD004735.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18020672","article-title":"Perinatal outcomes associated with latency in late preterm premature rupture of membranes","volume":"18","author":"Choi EK","year":"2021","unstructured":"Choi EK, Kim SY, Heo JM, Park KH, Kim HY, Choi BM, Kim HJ. Perinatal outcomes associated with latency in late preterm premature rupture of membranes. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph18020672","journal-title":"Int J Environ Res Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1969358","article-title":"Delivery indication matters for perinatal outcomes in late preterm newborns","volume":"35","author":"Monari F","year":"2022","unstructured":"Monari F, Chiossi G, Gargano G, Ballarini M, Baronciani D, Coscia A, Facchinetti F. Delivery indication matters for perinatal outcomes in late preterm newborns. J Matern Fetal Neonatal Med. 2022, 35:8257-66. 10.1080\/14767058.2021.1969358","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718954","article-title":"Active versus expectant management for preterm premature rupture of membranes at 34-36 weeks of gestation and the associated adverse perinatal outcomes","volume":"42","author":"Ferraz MF","year":"2020","unstructured":"Ferraz MF, Lima TS, Cintra SM, et al.. Active versus expectant management for preterm premature rupture of membranes at 34-36 weeks of gestation and the associated adverse perinatal outcomes. Rev Bras Ginecol Obstet. 2020, 42:717-25. 10.1055\/s-0040-1718954","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.02.002","article-title":"Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment","volume":"230","author":"Jung E","year":"2024","unstructured":"Jung E, Romero R, Suksai M, et al.. Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment. Am J Obstet Gynecol. 2024, 230:S807-40. 10.1016\/j.ajog.2023.02.002","journal-title":"Am J Obstet Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita AT","year":"2010","unstructured":"Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010, 37:339-54. 10.1016\/j.clp.2010.02.003","journal-title":"Clin Perinatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093329","article-title":"Intrapartum maternal fever and long-term infectious morbidity of the offspring","volume":"12","author":"Zamstein O","year":"2023","unstructured":"Zamstein O, Wainstock T, Sheiner E. Intrapartum maternal fever and long-term infectious morbidity of the offspring. J Clin Med. 2023, 12:10.3390\/jcm12093329","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.15492","article-title":"Is peripartum maternal fever alone a reliable predictor of neonatal sepsis? A single-centre, retrospective cohort study","volume":"57","author":"Gupta S","year":"2021","unstructured":"Gupta S, Forbes-Coe A, Rudd D, Kandasamy Y. Is peripartum maternal fever alone a reliable predictor of neonatal sepsis? A single-centre, retrospective cohort study. J Paediatr Child Health. 2021, 57:1420-5. 10.1111\/jpc.15492","journal-title":"J Paediatr Child Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1711725","article-title":"Clinical chorioamnionitis criteria are not sufficient for predicting intra-amniotic infection","volume":"35","author":"Maki Y","year":"2022","unstructured":"Maki Y, Furukawa S, Nakayama T, et al.. Clinical chorioamnionitis criteria are not sufficient for predicting intra-amniotic infection. J Matern Fetal Neonatal Med. 2022, 35:52-7. 10.1080\/14767058.2020.1711725","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.113988","article-title":"Perinatal infection, inflammation, preterm birth, and brain injury: a review with proposals for future investigations","volume":"351","author":"Reiss JD","year":"2022","unstructured":"Reiss JD, Peterson LS, Nesamoney SN, et al.. Perinatal infection, inflammation, preterm birth, and brain injury: a review with proposals for future investigations. Exp Neurol. 2022, 351:113988. 10.1016\/j.expneurol.2022.113988","journal-title":"Exp Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112922","article-title":"Chorioamnionitis: an update on diagnostic evaluation","volume":"11","author":"Carter SW","year":"2023","unstructured":"Carter SW, Neubronner S, Su LL, et al.. Chorioamnionitis: an update on diagnostic evaluation. Biomedicines. 2023, 11:10.3390\/biomedicines11112922","journal-title":"Biomedicines"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1618822","article-title":"Should the diagnostic criteria for suspected clinical chorioamnionitis be changed?","volume":"34","author":"Sung JH","year":"2021","unstructured":"Sung JH, Choi SJ, Oh SY, Roh CR. Should the diagnostic criteria for suspected clinical chorioamnionitis be changed?. J Matern Fetal Neonatal Med. 2021, 34:824-33. 10.1080\/14767058.2019.1618822","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.030","article-title":"Chorioamnionitis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Kachikis A","year":"2019","unstructured":"Kachikis A, Eckert LO, Walker C, et al.. Chorioamnionitis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2019, 37:7610-22. 10.1016\/j.vaccine.2019.05.030","journal-title":"Vaccine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/400639-neonatal-outcome-after-expectant-management-of-preterm-premature-rupture-of-membranes-pprom-between-340-and-366-weeks-of-gestation-a-single-center-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:39:14Z","timestamp":1758609554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/400639-neonatal-outcome-after-expectant-management-of-preterm-premature-rupture-of-membranes-pprom-between-340-and-366-weeks-of-gestation-a-single-center-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.92985","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}